Intimation under Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, an intimation is attached herewith
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gaudium IVF and Women Health Limited has informed the stock exchanges that Mr. Naveen Kumar (ICSI Membership No: A69788), who serves as the Company's Company Secretary, was designated as the Compliance Officer under Regulation 6(1) of the SEBI Listing Obligations and Disclosure Requirements, 2015. The appointment took effect from November 04, 2024. The intimation to the exchanges is dated February 27, 2026, indicating a delay of over a year in formally communicating this to the stock exchanges. Mr. Naveen Kumar will continue in his dual role as Company Secretary and Compliance Officer of the company.
This is a routine regulatory disclosure formalising an existing position. Shareholders are unlikely to see any material impact on stock price, though the significant delay in intimating the exchanges may raise minor governance compliance questions among vigilant investors.